Date:
July 6, 2026
Content:
The U.S. Food and Drug Administration (FDA) has released a Form 483 following an inspection of the Richmond VA Medical Center in Richmond, Virginia. This document highlights observations made by investigators regarding the facility’s sterile production operations.
The inspection, which concluded on May 12, 2026, focused on the medical center’s role as a producer of sterile products. A Form 483 is issued to firm management when an FDA investigator has observed conditions that may constitute violations of the Food, Drug, and Cosmetic Act. These observations serve as a notice of areas where the facility may need to improve its processes to meet regulatory standards.
The publication of this record in the FDA Electronic Reading Room allows for transparency regarding the compliance status of healthcare facilities. The medical center is expected to respond to these findings with a plan for corrective actions to ensure the continued safety and quality of the sterile products manufactured on-site.
Source: FDA OII FOIA Electronic Reading Room
Link:
http://www.fda.gov/about-fda/fda-commissioner/richmond-va-medical-center-richmond-va-483-issued-5122026
Keywords:
FDA, Form 483, Richmond VA Medical Center, Sterile Production, Inspection Report, Virginia